🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to evaluate the long term safety of ...
Status
Terminated
Location
Regeneron Research Site
Start Date
2018-09-28
Trial ID
NCT03694197
Treatments Being Tested
PCSK9 mediates immune checkpoint blockade resistance by downregulating tumo...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2023-05-16
Trial ID
NCT05553834
Treatments Being Tested
Atherosclerosis in the setting of HIV infection is distinct and includes in...
Status
Completed
Location
San Francisco General Hospital
Start Date
2018-04-30
Trial ID
NCT03207945
Treatments Being Tested
Primary Objective: To collect real-use (usability) data assessing the robu...
Status
Completed
Location
Investigational Site Number 8400024
Start Date
2018-03-29
Trial ID
NCT03415178
This study is researching an experimental drug called alirocumab, referred ...
Status
Recruiting
Location
Pinnacle Research Group
Start Date
2026-06-17
Trial ID
NCT07477704
Treatments Being Tested
Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but...
Status
Recruiting
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2024-03-22
Trial ID
NCT04968509
Treatments Being Tested
Background: Drinking alcohol can lead to swelling and injury in the liver....
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-10-19
Trial ID
NCT04781322
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 1560027
Start Date
2016-07-27
Trial ID
NCT02715726
The primary objective of the study is to evaluate the reduction of LDL-C by...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2017-11-10
Trial ID
NCT03175367
Treatments Being Tested
Primary Objective: To evaluate the effect of alirocumab on low-density lip...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2016-09-15
Trial ID
NCT02890992